Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in young women with PCOS are linked to higher blood pressure.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

High doses of finasteride cause cell growth and tumors in mice.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Spironolactone did not make hair thinner in women with excess hair growth.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Many women with hard-to-treat acne also have PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

150 kHz electromagnetic radiation might help improve PCOS in rats.